Serial Number 90274251
606

Registration Progress

Application Filed
Oct 23, 2020
Under Examination
Jun 8, 2021
Approved for Publication
Apr 13, 2021
Published for Opposition
Apr 13, 2021
Registered

Trademark Image

Basic Information

Serial Number
90274251
Filing Date
October 23, 2020
Published for Opposition
April 13, 2021
Abandonment Date
July 11, 2022
Drawing Code
2

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 11, 2022
Classes
005

Rights Holder

Marinus Pharmaceuticals, Inc.

03
Address
100 Matsonford Road
5 Radnor Corporate Center, Suite 500
Radnor, PA 19087

Ownership History

Marinus Pharmaceuticals, Inc.

Original Applicant
03
Radnor, PA

Marinus Pharmaceuticals, Inc.

Owner at Publication
03
Radnor, PA

Legal Representation

Attorney
Keith Barritt

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

15 events
Date Code Type Description Documents
Jul 11, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jul 11, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 7, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 3, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 3, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 3, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 8, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 13, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 13, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 24, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 11, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 27, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 12, 2020 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Dec 11, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 27, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of seizures and epilepsy, status epilepticus, encephalopathies, neurodegenerative disease, cerebrovascular disease, movement disorders, traumatic brain injury and other neurologic conditions, substance abuse, substance withdrawal, dementia, delirium, schizophrenia, bipolar disorder, psychosis, depression, and other psychiatric conditions

Additional Information

Design Mark
The mark consists of a circle enclosing a broken circle with a wave design in the center.

Classification

International Classes
005